Security key
151190113
- Security type / class
- Equity / *W EXP 07/16/202
- Total 13F shares
- 2,568,654
- Total 13F value
- $107,992
- Share change
- -309,855
- SEC-reported price per share
- $0.04
- Number of holders
- 11
- Value change
- -$12,390
- Number of buys
- 1
- Number of sells
- 5
Report period
Q1 2024
Institutions
11
Top holders
10
CELUW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Celularity Inc SEC filings
Celularity Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 151190113
Recent filing periods:
Ownership snapshot
Top reported holders of CELUW - Celularity Inc - *W EXP 07/16/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Dragasac Ltd
Disclosed value leader
Dragasac Ltd
Comparable rows
0/15
Latest evidence
16 Feb 2024
3/4/5
13F
Highest disclosed value: $7,485,632
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Dragasac Ltd has the largest disclosed position value at $7.49M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Dragasac Ltd's linked filing trail.
Disclosed position value
Top 5
Dragasac Ltd
$7.49M
STARR INTERNATIONAL CO INC
$3.81M
Sorrento Therapeutics, Inc.
$1.26M
Berhad Genting
$375K
GX Sponsor LLC
$24.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Dragasac Ltd |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$7,485,632
30,062,778 shares
|
— | 16 Jul 2021 |
| STARR INTERNATIONAL CO INC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$3,805,066
15,281,389 shares
|
— | 01 Mar 2022 |
| Sorrento Therapeutics, Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,257,556
5,050,427 shares
|
— | 29 Sep 2023 |
| Berhad Genting |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$375,000
3,000,000 shares
|
— | 20 Jun 2023 |
| GX Sponsor LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$24,900
100,000 shares
|
— | 16 Jul 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$923,595
3,733,206 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
2,568,654
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q2 2026 Across Filers
Q2 2026 holders
14
Q1 2024 holders
11
Holder diff
-3
| Investor | Q2 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q2 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend